These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9284427)

  • 21. Use of centrally acting sympatholytic agents in the management of hypertension.
    Oster JR; Epstein M
    Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New central mediators as targets of centrally acting antihypertensive drugs.
    van Zwieten PA
    Clin Exp Hypertens; 1996; 18(3-4):291-303. PubMed ID: 8743022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of centrally acting hypotensive drugs.
    van Zwieten PA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New concepts on central regulation of the blood pressure. Mode of action of clonidine and alpha-methyl DOPA (author's transl)].
    Kobinger W
    Wien Klin Wochenschr; 1977 Apr; 89(8):253-7. PubMed ID: 193305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Historic aspects in the identification of the I1 receptor and the pharmacology of imidazolines.
    Dominiak P
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():21-6. PubMed ID: 8068577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrally acting antihypertensive drugs. Present and future.
    van Zwieten PA
    Clin Exp Hypertens; 1999; 21(5-6):859-73. PubMed ID: 10423108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of clonidine in patients with essential hypertension with neurovascular contact of the rostral ventrolateral medulla.
    Sakuma T; Morimoto S; Aota Y; Takahashi N; Toyoda N; Kosaki A; Maehara M; Tanigawa N; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2010 Jun; 33(6):633-7. PubMed ID: 20379192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological properties of the central antihypertensive agent, moxonidine.
    Edwards LP; Brown-Bryan TA; McLean L; Ernsberger P
    Cardiovasc Ther; 2012 Aug; 30(4):199-208. PubMed ID: 21884003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
    Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The imidazoline receptor in control of blood pressure by clonidine and allied drugs.
    Reis DJ; Piletz JE
    Am J Physiol; 1997 Nov; 273(5):R1569-71. PubMed ID: 9374795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA
    J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renewed interest in centrally acting antihypertensive drugs.
    van Zwieten PA
    Cardiovasc J S Afr; 2000 Aug; 11(4):225-229. PubMed ID: 11447483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspects of tolerability of centrally acting antihypertensive drugs.
    Webster J; Koch HF
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S49-54. PubMed ID: 8872299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazoline antihypertensive drugs: a critical review on their mechanism of action.
    Szabo B
    Pharmacol Ther; 2002 Jan; 93(1):1-35. PubMed ID: 11916539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA; Peters SL
    Ann N Y Acad Sci; 1999 Jun; 881():420-9. PubMed ID: 10415946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.